I hate to say it, but I’ve started to forget how to write. While there’s always been something so satisfying about putting ...

After more than a decade, I broke up with Microsoft 365. I’d like to say I ditched the office suite for some nuanced reason, ...

ChatGPT is rolling out a deeper integration with Google Drive, allowing users to add Google Drive files to their ChatGPT ...

Explore how AI scribes can transform small medical practices by reducing administrative burdens, improving efficiency, and ...

AI companies are increasingly looking for ways to mark content generated by their models. Now, someone has built an open-source tool designed to remove some of those marks. A GitHub project called ...

At a recent doctor's appointment, I was asked to consent to an artificial intelligence assistant listening to my consultation ...

In April 2026, we added two new e-readers to this list. After months of testing, we've included the Durobo Krono, an open ...

Posts from this topic will be added to your daily email digest and your homepage feed. The included stylus is great for writing or annotating notes when you aren’t reading ebooks. The included stylus ...

This article first appeared on GuruFocus. Scribe Therapeutics (NASDAQ:SCTX), a clinical-stage developer of gene therapies for heart disease, surged 67% on Friday after raising $128.7 million in an ...

Scribe Therapeutics (Nasdaq: SCTX) visits the Nasdaq MarketSite in Times Square. Scribe is a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to ...

Scribe Therapeutics has overshot its own expectations with an IPO that's set to bring in $128.7 million for the in vivo gene editing outfit. Scribe is issuing 8.6 million shares—above the 7.1 million ...